Skip to main content
Jérôme AJ Becker on Muck Rack

Jérôme AJ Becker

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jérôme AJ

Contact Jérôme AJ, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Targeting mGlyR with nanobodies for depression - Nature Communications

|
By Thibaut Laboute, Stefano Zucca, Mansi Sharma, Shikha Singh Verified, Haiyong Peng, Christoph Rader, Julie Le Merrer, Appu K. Singh, Jérôme AJ Becker
| Nature Verified
Abstract Development of therapies for neuropsychiatric conditions is one of the greatest challenges of modern medicine. Common limitations of traditional small molecule drugs include poor efficacy, off-target side effects and difficult druggability of many targets. In this study, we report a different approach deploying small engineered single domain antibodies, known as nanobodies, for the treatment of depression, a prevalent neuropsychiatric condition.
Open in Who Shared Issue with article?
See all 1 articles